Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · Real-Time Price · USD
0.916
-0.044 (-4.54%)
Nov 20, 2024, 4:00 PM EST - Market closed
Cytosorbents Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Cytosorbents stock have an average target of 4.67, with a low estimate of 1.00 and a high estimate of 10. The average target predicts an increase of 409.88% from the current stock price of 0.92.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Cytosorbents stock from 3 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 3 | 3 | 3 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 4 | 4 | 4 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| D. Boral Capital | D. Boral Capital | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +991.82% | Nov 12, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Reiterates $1 | Hold | Reiterates | $1 | +9.18% | Nov 11, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +991.82% | Nov 8, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +991.82% | Nov 4, 2024 |
| EF Hutton | EF Hutton | Strong Buy Maintains $10 | Strong Buy | Maintains | $10 | +991.82% | Oct 22, 2024 |
Financial Forecast
Revenue This Year
41.11M
from 36.35M
Increased by 13.09%
Revenue Next Year
47.55M
from 41.11M
Increased by 15.68%
EPS This Year
-0.32
from -0.64
EPS Next Year
-0.15
from -0.32
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 43.4M | 52.3M | 61.9M | |
| Avg | 41.1M | 47.6M | 56.0M | |
| Low | 38.9M | 43.6M | 51.3M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | 19.3% | 27.2% | 30.2% | |
| Avg | 13.1% | 15.7% | 17.7% | |
| Low | 7.1% | 6.1% | 7.9% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | -0.30 | -0.04 | 0.05 | |
| Avg | -0.32 | -0.15 | -0.04 | |
| Low | -0.32 | -0.26 | -0.14 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|
| High | - | - | - | |
| Avg | - | - | - | |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.